Jessica Armstrong
Optometrist · Memphis, TNNPI 1336436344
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,523 of the $6,883 with a category attached, or 65.7%. 24 manufacturers reported payments, led by Carl Zeiss Meditec USA, Inc. at 28.4% of the total. Reporting peaked in 2023 at $2,378 and has fallen 59.6% since, to $960 in 2025. Among optometrist clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 160 payments — averaging $43.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec USA, Inc.$2K
- Mallinckrodt Hospital Products Inc.$886
- Sun Pharmaceutical Industries Inc.$767
- Visionary Optics LLC$615
- Alcon$529
- Novartis$326
- plus $2K from 18 others
What the payments were for
- Travel & lodging$1,55923%
- Food & beverage$4,52366%
- Education$1863%
- Gifts$6159%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec USA, Inc. | 3 | $1,956 |
| Mallinckrodt Hospital Products Inc. | 35 | $886 |
| Sun Pharmaceutical Industries Inc. | 19 | $767 |
| Visionary Optics LLC | 1 | $615 |
| Alcon | 10 | $529 |
| Novartis | 14 | $326 |
| Oyster Point Pharma, Inc. | 16 | $297 |
| Bausch & Lomb Americas Inc. | 12 | $268 |
| Harrow Eye, LLC | 5 | $264 |
| Mallinckrodt Enterprises LLC | 8 | $184 |
| ANI Pharmaceuticals, Inc. | 6 | $124 |
| Thea Pharma Inc. | 2 | $121 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $120 |
| AbbVie(2 entities) | 5 | $115 |
| Shire North American Group Inc | 3 | $63 |
| Eyevance Pharmaceuticals LLC | 3 | $51 |
| Amgen | 2 | $34 |
| Kala Pharmaceuticals, Inc. | 2 | $32 |
| Dompe US, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $26 |
| Heidelberg Engineering, Inc. | 1 | $25 |
| Carl Zeiss Meditec, Inc. | 1 | $19 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VisuMax$1,956
- CEQUA$236
- ARGOS$147
- Clareon PanOptix Pro$141
- XIIDRA$122
- VEVYE$117
- BROMSITE$113
- ACTIVEFOCUS$107
- ReSTOR$107
How this compares
$6,883 in reported general payments places this provider in the 95th percentile of 1,122 optometrist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 29 | $46,961 |
| CequaCyclosporine | 21 | $24,566 |
| RestasisCyclosporine | 21 | $23,615 |
| LumiganBimatoprost | 56 | $22,330 |
| ProlensaBromfenac Sodium | 11 | $7,638 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 28 | $6,404 |
| CombiganBrimonidine Tartrate/Timolol | 15 | $5,992 |
| Alphagan PBrimonidine Tartrate | 16 | $4,896 |
| Latanoprost | 107 | $1,289 |
| Prednisolone Acetate | 19 | $549 |
| Cromolyn Sodium | 28 | $417 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 34 | $417 |
| Timolol Maleate | 20 | $312 |
| Brimonidine Tartrate | 33 | $157 |
| MoxifloxacinMoxifloxacin Hcl | 12 | $150 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Alphagan P | $115 | $56,833108 claims |
| Bausch & Lomb Americas Inc.Xiidra | $268 | $46,96129 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $767 | $24,56621 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa | $120 | $7,63811 claims |
| AlconSimbrinza | $529 | $6,40428 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,122 optometrist providers in Tennessee.
Other optometrist in Memphis
- Christopher LievensMemphis$566K
- Whitney HauserMemphis$330K
- Melvin FriedmanMemphis$108K
- Desirae BrinkleyMemphis$51K
- Abagail KirkMemphis$14K
- Bradley HinesMemphis$12K
- David EvansMemphis$12K
- Daniel FullerMemphis$8K
- Dennis MathewsMemphis$8K
- Michael GerstnerMemphis$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.